spot the hidden danger - tb testing | blood test for tb · howthet-spot.tb testisused ......

2
The blood test for the detection of latent infection and TB disease. HOW THE T-SPOT .TB TEST IS USED Preventative screening amongst immunocompromised patient groups including: HIV, anti-TNFα, cancer chemotherapy, renal dialysis and transplant patients Targeted testing of high risk populations including: TB suspects, close contacts, immigrants, prisons, care-homes Pre-employment and regular screening of key professions: Healthcare professionals/occupational health T-SPOT.TB Test Advantages at a Glance Single blood sample. No repeat visit Unaffected by BCG vaccination and common non-tuberculous mycobacteria Unrivalled sensitivity, maintained even in the immunocompromised A cost-effective model for TB control Contact Oxford Immunotec for further information. T-SPOT® and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd. © Oxford Immunotec Ltd. 2013 All rights reserved. www.oxfordimmunotec.com Oxford Immunotec Limited, 94C Innovation Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, UK Tel: +44 (0)1235 442780 Fax: +44 (0)1235 442781 Email: [email protected] LP-TB-UK-V8 Antigens licensed from Statens Serum Institut Denmark Spot the hidden danger

Upload: lyquynh

Post on 19-Aug-2018

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Spot the hidden danger - TB Testing | Blood Test for TB · HOWTHET-SPOT.TB TESTISUSED ... HIV,anti-TNF α, ... LP-TB-UK-V8 Anti gens licensed fro m Statens Serum Institu t Denmar

The blood test for the detection oflatent infection and TB disease.

HOW THE T-SPOT.TB TEST IS USED

Preventative screening amongst immunocompromisedpatient groups including:HIV, anti-TNFα, cancer chemotherapy, renal dialysis and transplant patients

Targeted testing of high risk populations including:TB suspects, close contacts, immigrants, prisons, care-homes

Pre-employment and regular screening of key professions:Healthcare professionals/occupational health

T-SPOT.TB Test Advantages at a Glance

Single blood sample. No repeat visit

Unaffected by BCG vaccination and common non-tuberculousmycobacteria

Unrivalled sensitivity, maintained even in the immunocompromised

A cost-effective model for TB control

Contact Oxford Immunotec for further information.T-SPOT® and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd.© Oxford Immunotec Ltd. 2013 All rights reserved. www.oxfordimmunotec.comOxford Immunotec Limited, 94C Innovation Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, UKTel: +44 (0)1235 442780 Fax: +44 (0)1235 442781 Email: [email protected]

LP-TB-UK-V8

Antigens licensed fromStatens Serum Institut

Denmark

Spot the hidden danger

Page 2: Spot the hidden danger - TB Testing | Blood Test for TB · HOWTHET-SPOT.TB TESTISUSED ... HIV,anti-TNF α, ... LP-TB-UK-V8 Anti gens licensed fro m Statens Serum Institu t Denmar

HOW THE T-SPOT®.TB TEST HELPS YOU

The T-SPOT. test gives you accurate results in all patientgroups, time after time with minimum effort

SensitivityThe T-SPOT.TB test has a sensitivity of 95.6%1which is maintained even in theimmunocompromised2, 3 including HIV infected subjects4. Compared to other assays,the T-SPOT.TB test identifies a higher percentage of infected subjects and can be used tohelp rule-out active disease in TB suspects in just 24 hours.

SpecificityThe T-SPOT.TB test uses the RD1 antigens, ESAT-6 and CFP10, which ensure it does not crossreact with the BCG vaccine or most environmental mycobacteria5, 6. Since the specificity ofthe T-SPOT.TB test is 97.1%7, false positives are rare so unnecessary chemoprophylaxisand follow-up is avoided.

SimplicityThe T-SPOT.TB test requires a single blood sample so only one visit is required. Blood can becollected in Vacutainer®, Cell Preparation Tubes or any readily available lithium heparin blood tube.

Cost-effectivenessAs the T-SPOT.TB test dramatically reduces the number of false positive and false negativeresults, it helps ensure that therapy is targeted at people who are truly infected8,9.

HOW THE T-SPOT.TB TEST WORKS

For full technical details visit www.oxfordimmunotec.com

1. T-SPOT.TB Pivotal Clinical Trial (PI-TB-US-V1)2. Meier T. el al. Eur J Clin Microbiol Infect Dis 24: 529–536, 20053. Lee JY. et al. Eur Respir J 2006; 28: 24–304. Clarke S. et al. Clin Exp Immunol 2007 150(2):238-445. Adams L et al. Scandinavian Journal of Infectious Diseases.

2008, 1-8

6. van Leeuwen R et al. Eur Respir J 2007; 29: 605–6077. T-SPOT.TB Pivotal Clinical Trial (PI-TB-US-V1)8. Wrighton-Smith P. et al. Eur Respir J 2006; 28: 45–509. Diel R. et al. ERJ 2007 30: 321-332